Kyung Jin Kim;Hangil Park;Wei-meng Zhao;Maximiliano Vasquez
发明人:
Kyung Jin Kim,Wei-meng Zhao,Hangil Park,Maximiliano Vasquez
申请号：
US13284838
公开号：
US08603987B2
申请日:
2011.10.28
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
